Actelion (OTCMKTS:ALIOF) and Aphria (NYSE:APHA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability.
Insider and Institutional Ownership
10.1% of Aphria shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This table compares Actelion and Aphria’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk and Volatility
Actelion has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Comparatively, Aphria has a beta of 2.13, suggesting that its stock price is 113% more volatile than the S&P 500.
Valuation & Earnings
This table compares Actelion and Aphria’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Aphria||$179.29 million||5.89||-$12.48 million||($0.11)||-35.91|
Actelion has higher earnings, but lower revenue than Aphria.
This is a breakdown of current ratings and recommmendations for Actelion and Aphria, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aphria has a consensus price target of $8.21, suggesting a potential upside of 107.78%. Given Aphria’s higher probable upside, analysts clearly believe Aphria is more favorable than Actelion.
Aphria beats Actelion on 6 of the 8 factors compared between the two stocks.
Actelion Company Profile
Actelion Ltd. invests in companies that specialize in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller, and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland.
Aphria Company Profile
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Receive News & Ratings for Actelion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Actelion and related companies with MarketBeat.com's FREE daily email newsletter.